Literature DB >> 24534569

Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia.

Corrado Girmenia1, Alessandra Micozzi2, Alfonso Piciocchi3, Giuseppe Gentile2, Luigi Di Caprio4, Daniela Nasso4, Clara Minotti2, Saveria Capria2, Claudio Cartoni2, Giuliana Alimena2, Giovanna Meloni2, Sergio Amadori4, Robin Foà2, Adriano Venditti4.   

Abstract

We retrospectively evaluated, in a logistic-regression-model, the role of proven/probable invasive fungal diseases (PP-IFD), occurring during first induction chemotherapy, on the achievement of complete remission (CR) and overall survival (OS) in 198 acute myeloid leukemia (AML) patients. A PP-IFD was documented in 34 (17.2%) patients. Younger age, good performance status at AML diagnosis and no development of a PP-IFD (OR 4.09, 95% CI 1.71-9.81, p<0.0001) were independent factors associated to CR achievement. Younger age, good performance status, favorable genetic risk and no development of PP-IFD (HR 1.86, 95% CI 1.20-2.88, p=0.005) were independent factors associated to OS at 3 years.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute myeloid leukemia; Aspergillosis; Complete remission; Invasive fungal disease; Survival

Mesh：

Year:  2014        PMID： 24534569     DOI： 10.1016/j.leukres.2014.01.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  10 in total

1.  A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS.

Authors:  R J van de Peppel; P A von dem Borne; S le Cessie; M G J de Boer
Journal:  Bone Marrow Transplant       Date:  2017-05-15       Impact factor: 5.483

2.  Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension.

Authors:  Russell E Lewis; Dimitrios P Kontoyiannis; Pierluigi Viale; Eric M Sarpong
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

3.  The Current State of Antifungal Stewardship in Immunocompromised Populations.

Authors:  William Alegria; Payal K Patel
Journal:  J Fungi (Basel)       Date:  2021-04-30

Review 4.  Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.

Authors:  Melissa D Johnson; Russell E Lewis; Elizabeth S Dodds Ashley; Luis Ostrosky-Zeichner; Theoklis Zaoutis; George R Thompson; David R Andes; Thomas J Walsh; Peter G Pappas; Oliver A Cornely; John R Perfect; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2020-08-05       Impact factor: 5.226

5.  High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan.

Authors:  Jih-Luh Tang; Hsiang-Chi Kung; Weng-Chi Lei; Ming Yao; Un-In Wu; Szu-Chun Hsu; Chien-Ting Lin; Chi-Cheng Li; Shang-Ju Wu; Hsin-An Hou; Wen-Chien Chou; Shang-Yi Huang; Woei Tsay; Yao-Chang Chen; Yee-Chun Chen; Shan-Chwen Chang; Bor-Sheng Ko; Hwei-Fang Tien
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

6.  Acute myeloid leukaemia: challenges and real world data from India.

Authors:  Chepsy Philip; Biju George; Abhijeet Ganapule; Anu Korula; Punit Jain; Ansu Abu Alex; Kavitha M Lakshmi; Usha Sitaram; Fouzia N Abubacker; Aby Abraham; Auro Viswabandya; Vivi M Srivastava; Alok Srivastava; Poonkuzhali Balasubramanian; Vikram Mathews
Journal:  Br J Haematol       Date:  2015-04-09       Impact factor: 6.998

7.  Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.

Authors:  Rafael Cámara; Irmina Gozalbo; Manuel Jurado; Jaime Sanz; Belén Aragón; Santiago Grau
Journal:  Adv Ther       Date:  2017-08-14       Impact factor: 3.845

8.  A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from India.

Authors:  Biju George; Hari Menon; Dinesh Bhurani; Sharat Damodar; Shashi Apte; Tulika Seth; Ajay Sharma; Radhe Shyam; Pankaj Malhotra; Jose Easow; Kavitha M Lakshmi; Narendra Agrawal; Manju Sengar; K S Nataraj; Rayaz Ahmed; Sanjeevan Sharma; Alka Khadwal; Gaurav Prakash; Aby Abraham; Anup Devasia; Anu Korula; Vikram Mathews
Journal:  Indian J Hematol Blood Transfus       Date:  2019-08-26       Impact factor: 0.915

9.  Isavuconazole Therapy of Disseminated and Encephalic Saprochaete Capitata Infection in an Acute Myeloid Leukemia Patient Treated with Midostaurin.

Authors:  Salvatore Perrone; Chiara Lisi; Elettra Ortu La Barbera; Cristina Luise; Miriam Lichtner; Corrado Girmenia; Giuseppe Cimino
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-05-01       Impact factor: 2.576

10.  Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study.

Authors:  Chiara Cattaneo; Alessandro Busca; Doriana Gramegna; Francesca Farina; Anna Candoni; Monica Piedimonte; Nicola Fracchiolla; Chiara Pagani; Maria Ilaria Del Principe; Maria Chiara Tisi; Massimo Offidani; Rosa Fanci; Stelvio Ballanti; Angelica Spolzino; Marianna Criscuolo; Francesco Marchesi; Gianpaolo Nadali; Mario Delia; Marco Picardi; Margherita Sciumé; Valentina Mancini; Attilio Olivieri; Mario Tumbarello; Giuseppe Rossi; Livio Pagano
Journal:  Hemasphere       Date:  2019-11-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.